Literature DB >> 10397387

Apoptosis in dendritic cell biology.

H Matsue1, A Takashima.   

Abstract

Apoptosis or programmed cell death regulates many aspects in immunological homeostasis and, thus, controls the initiation, magnitude, duration, and termination of immune responses. Recent studies on dendritic cells (DC), including Langerhans cells (LC), have reinforced this concept by documenting that these antigen presenting cells express surface receptors and ligands that are known to mediate apoptotic cell death and that they are highly susceptible to apoptotic signals. In this review article, four major topics concerning apoptosis in the biology of DC will be overviewed: (a) molecular mechanisms of apoptosis; (b) DC apoptosis induced by various stimuli; (c) regulation of DC apoptosis; and (d) cross-priming and cross-tolerance induced by DC ingesting apoptotic bodies.

Mesh:

Year:  1999        PMID: 10397387     DOI: 10.1016/s0923-1811(98)00078-4

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  3 in total

Review 1.  Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors.

Authors:  Ivan Zanoni; Francesca Granucci
Journal:  J Mol Med (Berl)       Date:  2010-06-18       Impact factor: 4.599

2.  Induction of TRAIL- and TNF-alpha-dependent apoptosis in human monocyte-derived dendritic cells by microfilariae of Brugia malayi.

Authors:  Roshanak Tolouei Semnani; Priyanka Goel Venugopal; Lily Mahapatra; Jason A Skinner; Francoise Meylan; Daniel Chien; David W Dorward; Damien Chaussabel; Richard M Siegel; Thomas B Nutman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

3.  Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity.

Authors:  Brian M Janelsins; Alicia R Mathers; Olga A Tkacheva; Geza Erdos; William J Shufesky; Adrian E Morelli; Adriana T Larregina
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.